India will resume export of surplus Covid-19 vaccines in the fourth quarter of 2021 under the Vaccine Maitri' programme and to meet its commitment to the COVAX global pool.

India will resume export of surplus Covid-19 vaccines in the fourth quarter of 2021 under the Vaccine Maitri' programme and to meet its commitment to the COVAX global pool.